Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

The observed in vitro and in vivo benefit of combination treatment with anti-human immunodeficiency virus (HIV) agents prompted us to examine the potential of resistance development when two protease inhibitors are used concurrently. Recombinant HIV-1 (NL4-3) proteases containing combined resistance...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rose, R E, Gong, Y F, Greytok, J A, Bechtold, C M, Terry, B J, Robinson, B S, Alam, M, Colonno, R J, Lin, P F
Formato: Artigo
Idioma:Inglês
Publicado: 1996
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC39996/
https://ncbi.nlm.nih.gov/pubmed/8643685
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares